MAP3K7 and myeloproliferative disorder: Because of our previous findings describing a role of ABI1 in regulating NF‐κB signaling in hematopoietic stem/progenitor cells from MPN patients,24 we sought to further characterize the role of ABI1 in TAK1‐mediated regulation of NF‐κB.